Scholarlink

<p>Loss of functional chondrocytes contributes to cartilage degeneration. Autologous transplantation of adipose-derived mesenchymal stem cells (ASCs) offers a promising approach for cartilage repair; however, current differentiation protocols remain suboptimal. To improve chondrogenic outcomes, we supplemented the standard Chondrocyte Differentiation Medium (CDM1) with Avenanthramide C (Avn C), a compound primarily known for its anti-inflammatory and chondroprotective activity. Unexpectedly, Avn C enhanced COL2A1 protein deposition, the primary collagen type that is cartilage tissue-specific. Co-administration of chondroitin sulphate (CS), a major extracellular matrix component, further elevated the expressions of important chondrogenic genes including AGGRECAN, SOX9, and LRP1. Proteomic analysis revealed increased secretion of SERPINs and complement proteins, known regulators of cartilage homeostasis and chondrocyte function, in the presence of Avn C and CS. This work identified Avn C (besides for chondroprotection) and CS as synergistic enhancers of chondrogenic differentiation in ASCs, as evidenced by the expression of articular cartilage–specific markers LRP1 and AGGRECAN, supporting their relevance for regenerative applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Avenanthramide C and chondroitin sulphate promote chondrogenic differentiation of adipose-derived mesenchymal stem cells

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月11日

查看全文
  • Priscila Sun,
  • Winston Lim,
  • Shivatra C. Talchai,
  • Veerapol Khemarangsan

摘要

Loss of functional chondrocytes contributes to cartilage degeneration. Autologous transplantation of adipose-derived mesenchymal stem cells (ASCs) offers a promising approach for cartilage repair; however, current differentiation protocols remain suboptimal. To improve chondrogenic outcomes, we supplemented the standard Chondrocyte Differentiation Medium (CDM1) with Avenanthramide C (Avn C), a compound primarily known for its anti-inflammatory and chondroprotective activity. Unexpectedly, Avn C enhanced COL2A1 protein deposition, the primary collagen type that is cartilage tissue-specific. Co-administration of chondroitin sulphate (CS), a major extracellular matrix component, further elevated the expressions of important chondrogenic genes including AGGRECAN, SOX9, and LRP1. Proteomic analysis revealed increased secretion of SERPINs and complement proteins, known regulators of cartilage homeostasis and chondrocyte function, in the presence of Avn C and CS. This work identified Avn C (besides for chondroprotection) and CS as synergistic enhancers of chondrogenic differentiation in ASCs, as evidenced by the expression of articular cartilage–specific markers LRP1 and AGGRECAN, supporting their relevance for regenerative applications.